FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Apotex gets FDA ultimatum; Teva recalls propofol

Tools

> Apotex got an ultimatum from the FDA: Fix your manufacturing problems, or forget introducing new meds in the U.S. Report

> Teva, maker of the anesthetic propofol, has a massive recall underway following dozens of patients getting sick from two batches. Bacterial contamination is the chief suspect. Article

> EMCOR will provide facilities and energy management services for Patheon at the contract manufacturer's three U.S. plants in Manati and Caguas, Puerto Rico, and Cincinnati. Release

> A groundbreaking ceremony took place recently for a planned 200,000-square-foot, $30-million Viva Biopharm manufacturing plant in Blaine, WA. Article

> The Pharmaceutical Council of Nigeria cites an increasing rate of fake pharmaceutical products in circulation, and attributed the trend to the failure of manufacturers to conform to standards. Article


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FiercePharma Manufacturing Email Newsletter:
Comments (1) | Post a comment
More stories about recall   manufacturing problem   bacterial contamination  

Comments

Pharma manufacturers are the problem.
They do dump rejected OR EXPERIMENTAL lots in Africa .

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.